Enterprise Value

3.759B

Cash

262.4M

Avg Qtr Burn

-52.95M

Short % of Float

7.48%

Insider Ownership

1.93%

Institutional Own.

87.15%

Qtr Updated

12/31/22


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date